In our new webinar series, Risk Management for Your Life Sciences Company, we discuss the insurance and risk management milestones life science companies should prepare for as they move from early funding through clinical...more
6/27/2025
/ Biotechnology ,
Clinical Trials ,
Commercial Insurance Policies ,
Cyber Insurance ,
D&O Insurance ,
Initial Public Offering (IPO) ,
Liability Insurance ,
Life Sciences ,
Popular ,
Risk Management ,
Supply Chain
From lab to commercialization: Navigate the evolving risks of life science companies -
Life science companies face rapidly evolving risks—from navigating insurance needs during early funding stages to understanding...more
6/5/2025
/ Artificial Intelligence ,
Biotechnology ,
C-Suite Executives ,
Clinical Laboratories ,
Clinical Trials ,
Commercial Insurance Policies ,
Cyber Insurance ,
Early Stage Companies ,
Emerging Growth Companies ,
Initial Public Offering (IPO) ,
Insurance Industry ,
Life Sciences ,
Research and Development ,
Risk Management ,
Risk Mitigation ,
Webinars
Private to Public Timeline -
Click/tap an area of the timeline to learn more about the D&O insurance process for companies going public. While the timeline below is specific to IPO companies, the milestones are relevant to...more
Non-US companies are attracted to going public on a US exchange for a variety of reasons, such as access to capital, increased liquidity, and in some cases, more flexible rules and regulations compared to other markets....more
Becoming a public company is a big undertaking for any private company; there is added complexity for foreign filers, which is to say private issuers incorporated under the laws of a country other than the United States. One...more